Posts tagged ophthalmic medical device
Roth starts IRIDEX at buy

Roth Capital Partners initiated coverage of IRIDEX (NASDAQ:IRIX) with a “buy” rating and $20 price target. The stock closed at $13.22 on Dec. 20.

Read More